English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 856839      Online Users : 938
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/2983


    Title: Internal radiotherapy and dosimetric study for In-111/Lu-177-pegylated liposomes conjugates in tumor-bearing mice
    Authors: Wang, HE;Yu, HM;Lu, YC;Heish, NN;Tseng, YL;Huang, KL;Chuang, KT;Chen, CH;Hwang, JJ;Lin, WJ;Wang, SJ;Ting, G;Whang-Peng, J;Deng, WP
    Contributors: National Institute of Cancer Research
    Abstract: In vivo characterization and dosimetric analysis has been performed to evaluate the potential of pegylated liposomes as carriers of radionuclides in tumor internal radiotherapy. Methods: The DTPA/PEG-liposomes were synthesized with a medium size of 110 nm, conjugated with In-111/Lu-177-(oxine)(3) to afford In-111/Lu-177-liposome. The stability of In-111/Lu-177-liposome in serum was investigated. The biodistribution, scintigraphic imaging and pharmacokinetics of In-111/Lu-177-liposomes after intravenous(i.v.) injection into C-26 tumor-bearing BALB/cByJ mice were studied. Radiation dose was estimated by MIRD-III program. Results: The incorporation efficiency of In-111/Lu-177 into liposomes was 95%. After incubation at 37 degrees C for 72h in serum, more than 83% of radioactivity was still retained in the intact In-111/Lu-177-liposomes. The biodistribution of In-111-liposomes showed that the radioactivity in the blood decreased from 23.14 +/- 8.16%ID/g at 1 h to 0.02 +/- 0.00% ID/g at 72h post-injection (p.i.), while reaching its maximum accumulation in tumors at 48 h p.i., with half-life in blood of 10.2 h. The results were supported by that of Lu-177-liposomes. Scintigraphic imaging with In-111-liposomes showed unambiguous tumor images at 48 It p.i. Dose estimation showed that the absorbed dose in tumor from Lu-177-fposornes was 5.74 x 10(-5) Gy/MBq. Conclusions: This study provides an in vivo characterization and dosimetric evaluation for the use of liposome systems as carriers in targeted radionuclide therapy. The results suggest that adequate tumor targeting as well as dose delivered to tumors could be achieved by the use of radionuclide targeted liposomes.
    Keywords: Instruments & Instrumentation;Nuclear Science & Technology;Physics, Particles & Fields;Spectroscopy
    Date: 2006-12-20
    Relation: Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 2006 Dec;569(2):533-537.
    Link to: http://dx.doi.org/10.1016/j.nima.2006.08.124
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0168-9002&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000243241300084
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33751420619
    Appears in Collections:[彭汪嘉康(1996-2007)] 會議論文/會議摘要

    Files in This Item:

    File Description SizeFormat
    000243241300084.pdf251KbAdobe PDF1115View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback